Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed May 9, 2012 · 10-Q · 39 days after period end · 0001140361-12-023967
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$2.14M | -$4.44M |
| EPS Diluted | -$0.02 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 9, 2012 · 39 d after period end
